Shopping Cart
Remove All
Your shopping cart is currently empty
Gosuranemab (BIIB092) is a humanised monoclonal antibody targeting N-terminal tau, inhibiting the propagation and aggregation of pathological tau proteins for potential application in Alzheimer's disease.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $290 | - | In Stock | |
| 5 mg | $755 | - | In Stock | |
| 10 mg | $1,280 | - | In Stock |
| Description | Gosuranemab (BIIB092) is a humanised monoclonal antibody targeting N-terminal tau, inhibiting the propagation and aggregation of pathological tau proteins for potential application in Alzheimer's disease. |
| In vitro | Pre-incubation of Gosuranemab with AD-tau significantly inhibited tau aggregation in mouse primary cortical neurons [2]. |
| In vivo | Gosuranemab reduces tau aggregation in the cerebrospinal fluid of transgenic mice, inhibits microglial activation, and thereby improves their cognitive dysfunction [2]. |
| Synonyms | IPN007, IPN 007, BMS-986168, BIIB092, BIIB 092 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Cas No. | 1788032-39-2 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.